MedEquities Realty Trust Inc (MRT) Director Bluemountain Capital Managemen Sells 7,200 Shares

MedEquities Realty Trust Inc (NYSE:MRT) Director Bluemountain Capital Managemen sold 7,200 shares of the company’s stock in a transaction that occurred on Wednesday, November 21st. The shares were sold at an average price of $7.16, for a total transaction of $51,552.00. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.

Bluemountain Capital Managemen also recently made the following trade(s):

  • On Monday, November 19th, Bluemountain Capital Managemen sold 1,514 shares of MedEquities Realty Trust stock. The shares were sold at an average price of $7.48, for a total transaction of $11,324.72.
  • On Friday, November 16th, Bluemountain Capital Managemen sold 28,027 shares of MedEquities Realty Trust stock. The shares were sold at an average price of $7.52, for a total transaction of $210,763.04.
  • On Wednesday, November 14th, Bluemountain Capital Managemen sold 57,234 shares of MedEquities Realty Trust stock. The shares were sold at an average price of $7.81, for a total transaction of $446,997.54.
  • On Monday, November 12th, Bluemountain Capital Managemen sold 37,530 shares of MedEquities Realty Trust stock. The shares were sold at an average price of $8.74, for a total transaction of $328,012.20.
  • On Thursday, November 8th, Bluemountain Capital Managemen sold 35,783 shares of MedEquities Realty Trust stock. The shares were sold at an average price of $8.60, for a total transaction of $307,733.80.
  • On Tuesday, November 6th, Bluemountain Capital Managemen sold 25,765 shares of MedEquities Realty Trust stock. The shares were sold at an average price of $8.58, for a total transaction of $221,063.70.
  • On Friday, November 2nd, Bluemountain Capital Managemen sold 25,000 shares of MedEquities Realty Trust stock. The shares were sold at an average price of $8.39, for a total transaction of $209,750.00.
  • On Wednesday, October 31st, Bluemountain Capital Managemen sold 10,000 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $8.45, for a total transaction of $84,500.00.
  • On Monday, October 29th, Bluemountain Capital Managemen sold 11,695 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $8.39, for a total transaction of $98,121.05.
  • On Thursday, October 25th, Bluemountain Capital Managemen sold 25,546 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $8.45, for a total transaction of $215,863.70.

NYSE:MRT opened at $7.14 on Friday. The company has a market cap of $228.77 million, a price-to-earnings ratio of 6.35 and a beta of 0.65. MedEquities Realty Trust Inc has a fifty-two week low of $6.99 and a fifty-two week high of $12.00.

MedEquities Realty Trust (NYSE:MRT) last released its quarterly earnings data on Monday, November 12th. The financial services provider reported ($0.07) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.18 by ($0.25). MedEquities Realty Trust had a return on equity of 3.39% and a net margin of 19.98%. The business had revenue of $9.68 million during the quarter, compared to analyst estimates of $17.72 million. As a group, equities analysts expect that MedEquities Realty Trust Inc will post 0.89 EPS for the current year.

Several institutional investors have recently added to or reduced their stakes in MRT. Los Angeles Capital Management & Equity Research Inc. acquired a new stake in shares of MedEquities Realty Trust in the second quarter worth $131,000. People s United Financial Inc. acquired a new stake in shares of MedEquities Realty Trust in the second quarter worth $158,000. Bank of Montreal Can acquired a new stake in shares of MedEquities Realty Trust in the second quarter worth $160,000. Raymond James Trust N.A. acquired a new stake in shares of MedEquities Realty Trust in the third quarter worth $161,000. Finally, California Public Employees Retirement System acquired a new stake in shares of MedEquities Realty Trust in the second quarter worth $171,000. 90.81% of the stock is owned by institutional investors.

MRT has been the topic of a number of recent analyst reports. Zacks Investment Research downgraded shares of MedEquities Realty Trust from a “buy” rating to a “hold” rating in a research note on Saturday, August 11th. JMP Securities set a $12.00 price target on shares of MedEquities Realty Trust and gave the stock a “buy” rating in a research note on Tuesday, October 23rd. Citigroup downgraded shares of MedEquities Realty Trust from a “neutral” rating to a “sell” rating and cut their price target for the stock from $10.00 to $9.00 in a research note on Friday, September 14th. ValuEngine downgraded shares of MedEquities Realty Trust from a “sell” rating to a “strong sell” rating in a research note on Wednesday, August 8th. Finally, Raymond James cut their price target on shares of MedEquities Realty Trust from $12.00 to $10.00 and set a “buy” rating on the stock in a research note on Tuesday. Two research analysts have rated the stock with a sell rating, four have issued a hold rating and four have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus price target of $11.00.

ILLEGAL ACTIVITY WARNING: “MedEquities Realty Trust Inc (MRT) Director Bluemountain Capital Managemen Sells 7,200 Shares” was originally reported by WKRB News and is the sole property of of WKRB News. If you are accessing this story on another publication, it was copied illegally and republished in violation of United States and international copyright & trademark laws. The original version of this story can be accessed at https://www.wkrb13.com/2018/11/24/medequities-realty-trust-inc-mrt-director-bluemountain-capital-managemen-sells-7200-shares.html.

MedEquities Realty Trust Company Profile

MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios.

Further Reading: How are Outstanding Shares Different from Authorized Shares?

Insider Buying and Selling by Quarter for MedEquities Realty Trust (NYSE:MRT)

Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply